more_reports

The Latest Regenerative Medicine Articles from Streetwise Reports

New Blood Cancer Treatment Shows Continued Response

Research Report
  ()
The biotech behind this cell therapy has numerous near-term catalysts related to its pipeline, noted a Wedbush report.
Tags: Regenerative Medicine

Regenerative Med Co. Granted Second Tissue License

Research Report
  ()
With these expanded capabilities, the biotech may increase revenue generation and continue its clinical trial, noted a Roth MKM report.
Tags: Regenerative Medicine

Regenerative Medicine Co. May Have Solution to Delivering Cell Treatments

  ()
This Canadian life sciences firm is developing an implantable cell-containing pouch, shown in clinical trial data thus far to be safe, well-tolerated and effective. Learn why several analysts rate the company Buy.
Tags: Regenerative MedicineMedical Devices

Trial Data Help Position Cell Pouch for Commercial Success

Research Report
  ()
The upside implied in the target price on this Canadian firm, developing regenerative medicine platform technologies, is 1,900%, noted an H.C. Wainwright & Co. report.
Tags: Medical DevicesRegenerative Medicine

Co's. Cell Pouch Performs Well in Study

Research Report
  ()
Data show the device keeps the incorporated therapeutic cells alive and functioning for at least five years, noted a Leede Financial Inc. report.
Tags: Regenerative MedicineMedical Devices

Implanted Cell Device Reaches 5 Year Milestone

Research Report
  ()
This pouch, loaded with pancreatic islet cells, is being evaluated in patients with insulin-dependent Type 1 diabetes, noted a Ventum Capital Markets report.
Tags: Medical DevicesRegenerative Medicine

Showing Results: 1 to 6 of 6